Oshrat E Tayer-Shifman

537 total citations
31 papers, 335 citations indexed

About

Oshrat E Tayer-Shifman is a scholar working on Rheumatology, Immunology and Surgery. According to data from OpenAlex, Oshrat E Tayer-Shifman has authored 31 papers receiving a total of 335 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Rheumatology, 8 papers in Immunology and 5 papers in Surgery. Recurrent topics in Oshrat E Tayer-Shifman's work include Systemic Lupus Erythematosus Research (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Oshrat E Tayer-Shifman is often cited by papers focused on Systemic Lupus Erythematosus Research (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Oshrat E Tayer-Shifman collaborates with scholars based in Israel, Canada and United States. Oshrat E Tayer-Shifman's co-authors include Eldad Ben‐Chetrit, Zahi Touma, Yuval Tal, Ophir Ilan, Jiandong Su, Kathleen Bingham, Alon Y. Hershko, Shafik Khoury, Ori Wand and Emire Seyahi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Medicine.

In The Last Decade

Oshrat E Tayer-Shifman

30 papers receiving 333 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oshrat E Tayer-Shifman Israel 12 157 78 60 54 47 31 335
S. Yılmaz-Öner Türkiye 11 187 1.2× 78 1.0× 35 0.6× 37 0.7× 18 0.4× 27 290
Cemal Beş Türkiye 11 187 1.2× 99 1.3× 84 1.4× 72 1.3× 63 1.3× 68 464
Timur Pırıldar Türkiye 10 175 1.1× 59 0.8× 83 1.4× 27 0.5× 62 1.3× 20 411
Yikai Yu China 10 85 0.5× 57 0.7× 62 1.0× 93 1.7× 48 1.0× 21 370
Khader N. Mustafa Jordan 10 134 0.9× 72 0.9× 35 0.6× 30 0.6× 38 0.8× 19 309
Romain Paule France 10 105 0.7× 80 1.0× 61 1.0× 56 1.0× 17 0.4× 25 332
E. N. Griep Netherlands 12 350 2.2× 84 1.1× 22 0.4× 82 1.5× 110 2.3× 22 562
K. Wildhagen Germany 9 215 1.4× 70 0.9× 123 2.0× 35 0.6× 35 0.7× 20 369
Evripidis Kaltsonoudis Greece 11 230 1.5× 156 2.0× 21 0.3× 49 0.9× 22 0.5× 25 426

Countries citing papers authored by Oshrat E Tayer-Shifman

Since Specialization
Citations

This map shows the geographic impact of Oshrat E Tayer-Shifman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oshrat E Tayer-Shifman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oshrat E Tayer-Shifman more than expected).

Fields of papers citing papers by Oshrat E Tayer-Shifman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oshrat E Tayer-Shifman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oshrat E Tayer-Shifman. The network helps show where Oshrat E Tayer-Shifman may publish in the future.

Co-authorship network of co-authors of Oshrat E Tayer-Shifman

This figure shows the co-authorship network connecting the top 25 collaborators of Oshrat E Tayer-Shifman. A scholar is included among the top collaborators of Oshrat E Tayer-Shifman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oshrat E Tayer-Shifman. Oshrat E Tayer-Shifman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tayer-Shifman, Oshrat E, Irina Kenis, Sydney Benchetrit, et al.. (2025). Clinical experience with sodium–glucose transport 2 (SGLT2) inhibitors in patients with systemic lupus erythematosus. International Urology and Nephrology.
2.
Sagy, Iftach, Ran Abuhasira, Yosef S. Haviv, et al.. (2025). Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: A national cohort study. Seminars in Arthritis and Rheumatism. 73. 152746–152746. 1 indexed citations
3.
Cohen‐Hagai, Keren, Mor Saban, Sydney Benchetrit, et al.. (2025). Prevalence, Risk Factors, and Outcomes of Chronic Kidney Disease in Patients With Systemic Lupus Erythematosus With and Without Lupus Nephritis. The Journal of Rheumatology. 52(9). 902–908. 1 indexed citations
4.
Neumark, Eran, et al.. (2024). Mitigating overuse of antinuclear antibody (ANA) testing through educational intervention: a study in internal medicine and neurology departments. Clinical Rheumatology. 43(12). 3935–3939. 1 indexed citations
5.
Feld, Joy, Oshrat E Tayer-Shifman, Jiandong Su, Melanie Anderson, & Zahi Touma. (2024). Primary headache in SLE –systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. 69. 152566–152566. 2 indexed citations
6.
Caspi, Michal, et al.. (2024). Wnt signaling regulates chemokine production and cell migration of circulating human monocytes. Cell Communication and Signaling. 22(1). 229–229. 4 indexed citations
7.
Kenis, Irina, et al.. (2024). #1720 Insights from sodium-glucose transport 2 (SGLT2) inhibitors treatment in patients with systemic lupus erythematosus. Nephrology Dialysis Transplantation. 39(Supplement_1). 1 indexed citations
8.
Tayer-Shifman, Oshrat E, Robin Green, Patricia Katz, et al.. (2022). Assessing the Utility of the Montreal Cognitive Assessment in Screening for Cognitive Impairment in Patients With Systemic Lupus Erythematosus. Arthritis Care & Research. 75(3). 569–577. 12 indexed citations
9.
Parikh, Roma, Oshrat E Tayer-Shifman, Oded Kimhi, et al.. (2022). Steroid treatment suppresses the CD4+ T-cell response to the third dose of mRNA COVID-19 vaccine in systemic autoimmune rheumatic disease patients. Scientific Reports. 12(1). 21056–21056. 5 indexed citations
10.
Tayer-Shifman, Oshrat E, Shelly Tartakover Matalon, Oded Kimhi, et al.. (2022). Immunogenicity and safety of the mRNA-based BNT162b2 vaccine in systemic autoimmune rheumatic diseases patients. Clinical Rheumatology. 41(12). 3879–3885. 7 indexed citations
11.
Tayer-Shifman, Oshrat E, Kathleen Bingham, & Zahi Touma. (2021). Neuropsychiatric Systemic Lupus Erythematosus in Older Adults: Diagnosis and Management. Drugs & Aging. 39(2). 129–142. 10 indexed citations
12.
Bingham, Kathleen, et al.. (2020). Measures of Cognition in Rheumatic Diseases. Arthritis Care & Research. 72(S10). 660–675. 8 indexed citations
13.
Wand, Ori, Oshrat E Tayer-Shifman, Shafik Khoury, & Alon Y. Hershko. (2018). A practical approach to infarction of the spleen as a rare manifestation of multiple common diseases. Annals of Medicine. 50(6). 494–500. 28 indexed citations
14.
Zigmond, Ehud, Oshrat E Tayer-Shifman, Gadi Lalazar, et al.. (2014). β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. SHILAP Revista de lepidopterología. 11 indexed citations
15.
Yaʼacov, Ami Ben, Ehud Zigmond, Oshrat E Tayer-Shifman, et al.. (2014). β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. Journal of Inflammation Research. 7. 151–151. 28 indexed citations
16.
Tayer-Shifman, Oshrat E, et al.. (2014). Cogan's Syndrome—Clinical Guidelines and Novel Therapeutic Approaches. Clinical Reviews in Allergy & Immunology. 47(1). 65–72. 42 indexed citations
17.
Cohen, Matan J., Suhail Aamar, Oshrat E Tayer-Shifman, et al.. (2012). Pulmonary Hemorrhage in Antiphospholipid Antibody Syndrome. The Journal of Rheumatology. 39(8). 1628–1631. 15 indexed citations
18.
Tayer-Shifman, Oshrat E & Eldad Ben‐Chetrit. (2011). FAMILIAL MEDITERRANEAN FEVER AND HYPERCOAGULABILITY. SHILAP Revista de lepidopterología. 3(1). e2011017–e2011017. 11 indexed citations
19.
Tayer-Shifman, Oshrat E, Yakir Rottenberg, & Mony Shuvy. (2009). Gemcitabine-Induced Supraventricular Tachycardia. Tumori Journal. 95(4). 547–549. 6 indexed citations
20.
Tayer-Shifman, Oshrat E, Mony Shuvy, & Alon Y. Hershko. (2009). Mesalamine-Induced Multiple Pulmonary Cavitary Nodules Associated With Cytoplasmic Antineutrophil Cytoplasmic Antibody (c-ANCA). JCR Journal of Clinical Rheumatology. 15(5). 256–257. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S. Yılmaz-Öner Breakdown of academic impact, for papers by Cemal Beş Breakdown of academic impact, for papers by Timur Pırıldar Breakdown of academic impact, for papers by Yikai Yu Breakdown of academic impact, for papers by Khader N. Mustafa Breakdown of academic impact, for papers by Romain Paule Breakdown of academic impact, for papers by E. N. Griep Breakdown of academic impact, for papers by K. Wildhagen Breakdown of academic impact, for papers by Evripidis Kaltsonoudis
Rankless by CCL
2026